Convention panels which introduce the "Ear- Resistable" campaign, at the NAPNAP (National Association of Pediatric Nurse Practitioners) convention in Chicago (March 19th –March 22).
Wall graphic for a booth at the AAAAI (American Academy of Allergy, Asthma & Immunology) in Orland, FL (March 2- March 5 2018) designed to attract HCPs attention, so they can learn more about Pazeo.
Internal training piece which explains to the field why a new campaign was created and what benefits this campaign offers. It will also explain how it is going to change their conversations with ECPs.
Simbrinza convention panels for the American Academy of Ophthalmology (AAO) convention (November 11 – November 14, 2017), consisting of one 10ft by 10ft static wall panel holding two digital screens (one static one interactive)
Looping panels which displayed DBV’s disease awareness campaign to the HCP community in advance of the full campaign. The ACAAI Annual Meeting (Oct 26-30) presented an opportunity for Viaskin Peanut to build anticipation for the upcoming HCP campaign and engage/capture allergists into RM program.
Adherence emails that educate patients on the importance of daily maintenance medication and how SPIRIVA RESPIMAT fits into their daily lifestyle. These emails are meant to encourage new behavior patterns by providing education on the need for each asthma medication and tips/tools to reinforce daily use.
The Ask: Create a FASENRA lifecycle management (LCM) unbranded campaign that will optimize AZ’s ownership of the theme that eosinophils are the drivers of inflammation in multiple diseases, which can be used across different mediums and executions both internally and externally (globally). This will be created to ensure that AZ can optimally own the “eosinophil” space within the full spectrum of therapeutic areas that will benefit from FASENRA’s unique eosinophil-clearing MOA.
VERSION CONTROL- When discussing asthma with doctors, we know that patients aren’t being totally open about their symptoms. Stuck in an “it is what it is” mentality, patients think that some of their symptoms aren’t worth mentioning. This campaign gets patients to question their own role in getting true control over their asthma.
